we only delivers trusted quality products. Plenum Biotech is an ISO 9001:2008 certified company and delivering products with a promised quality. We have thousands of products at great quality, timely delivery and with reasonable price range.we also ensure our PCD Pharma clients of round-the-clock support and assistance. We ensure latest product range at affordable prices.
Plenum Biotech help entrepreneurs make a mark in pharmaceutical industry by offering PCD Pharma Franchise opportunities at affordable prices. We provide PCD Pharma Franchise for every destination in India. Complete support by the experts helps new entrants reap the benefits of the industry.Serious, dedicated and experienced person are most welcome for sole Marketing and Distribution rights.
The facilities and location of the factory have created an extra edge for manufacturing and distributing the products. The factory consists of Production department, R&D department, Accounts department and other sub-departments.The factory is operating with experienced and hard working employees. It is equipped with sophisticated, modern and quality control equipments.
With the Wise Guidance and sheer Hard work of our Director Mr. Neeraj Sharda. Our Company has become one of the most progressive pharmaceutical Company.At Plenum Biotech We create value in the full pharmaceutical value chain from developing to manufacturing and successfully marketing pharmaceuticals drugs and we take pride in doing this in an innovative, responsible and cost-efficient way. Plenum Biotech currently conducts operations in Pan INDIA and over the next few years, will also expand outside with the aim of becoming a global player.
Our corporate culture and close collaboration with development and manufacturing partners are integral parts of our effort to deliver quality products at affordable prices. We offer a product portfolio consisting of a broad range of high quality drugs for all major therapeutic areas. Our products are originated where the efficacy and safety are well documented. Through our many collaborating partners, we have access to a vast range of technology platforms, enabling us to develop and enhance the intellectual property of our product portfolio.
Our strategy of developing products based on well-known substances with an improved value to patients results in a product portfolio with a significant market potential. We achieve this with a relatively short development time, low risk, and limited investment.